Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

Fintel reports that on October 10, 2025, Morgan Stanley maintained coverage of Moderna (NasdaqGS:MRNA) with a Equal-Weight ...

How is VOO stock faring? The Vanguard S&P 500 ETF is down 1.38% in the past five days but up 14.55% year-to-date. Fund Flows ...

This technical note explores a novel poly(A) tail modification that enhances total protein expression and extends expression ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this biotech stock.

FORT LAUDERDALE, FL / ACCESS Newswire / October 14, 2025 / Sunshine Biopharma (NASDAQ:SBFM) is the kind of company that keeps the market honest. On paper, it's small, barely a rounding error next to t ...

EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...

Penn Wharton professor Exequiel Hernandez shares research on the spillover impact on jobs, innovation, and company ...